Basic Study on the Development of Novel and Ultrasensitive Immunoassay for Biological Substances
生物物质新型超灵敏免疫分析技术发展的基础研究
基本信息
- 批准号:01580168
- 负责人:
- 金额:$ 1.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1989
- 资助国家:日本
- 起止时间:1989 至 1990
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Ultrasensitive enzyme immunoassay methods not only for antigens but also for antibodies and haptens have been developed. These methods are based on a noncompetitive type of assay using solid phase rather than a competitive one. One of the greatest obstacles limiting the sensitivity of noncompetitive immunoassay methods using solid phase is the nonspecific binding of labeled reactants to solid phase. A novel method (immune complex transfer immunoassay method) to overcome this difficulty has been developed. In the initially developed method, antibodies in test serum were reacted with dinitrophenylated biotinylated antigen. The complex formed was trapped onto (anti-dinitrophenyl group) IgG-coated solid phase. The solid phase was washed to eliminate nonspecific immunoglobulins. The complex was eluted from the solid phase with dinitrophenyl-L-lysine, again trapped onto avidin (streptavidin) -coated solid phase and finally measured by reaction with (anti-immunoglobulin) Fab' -enzyme conjugat … More e. Namely, the complex of antibodies and dinitrophenylated biotinylated antigen was transferred from one solid to another, effectively eliminating nonspecific immunoglobulins nonspecifically adsorbed onto the first solid phase. By this method with and without further modifications, the sensitivity for antibodies in serum has been considerably improved, and applications were made to measure low levels of antibodies against human T-cell leukemia virus and human immunodeficiency virus, which are not detectable by conventional methods. The same principle of immune complex transfer has been applied to the detection of antigens, and one milliattomole (600 molecules) of human ferritin has been detected. Ultrasensitive, noncompetitive immunoassay methods to measure attomole amounts of haptens with amino groups have also been developed. Haptens, especially peptides, were biotinylated by using N-hydroxysuccinimidobiotin, and measured by using enzyme-labeled anti-peptide Feb' and streptavidin- coated solid phase (hetero-two-site enzyme immunoassay). Less
超灵敏的酶免疫分析方法不仅适用于抗原,而且适用于抗体和半抗原。这些方法是基于使用固相的非竞争性类型的测定,而不是竞争性的。限制使用固相的非竞争性免疫测定方法的灵敏度的最大障碍之一是标记反应物与固相的非特异性结合。一种新的方法(免疫复合物转移免疫测定法),以克服这一困难已被开发。在最初开发的方法中,测试血清中的抗体与二硝基苯化生物素化抗原反应。将形成的复合物捕获到(抗二硝基苯基)IgG包被的固相上。洗涤固相以除去非特异性免疫球蛋白。用二硝基苯基-L-赖氨酸从固相上洗脱复合物,再次捕获到抗生物素蛋白(链霉抗生物素蛋白)包被的固相上,最后通过与(抗免疫球蛋白)Fab' -酶缀合物反应进行测量。 ...更多信息 e.即,抗体和二硝基苯基化生物素化抗原的复合物从一种固体转移到另一种固体,有效地消除了非特异性吸附在第一固相上的非特异性免疫球蛋白。通过该方法,无论是否进一步修改,血清中抗体的灵敏度都得到了显著提高,并应用于测量常规方法检测不到的抗人T细胞白血病病毒和人免疫缺陷病毒的低水平抗体。免疫复合物转移的相同原理已被应用于抗原的检测,并已检测到1毫阿摩尔(600分子)的人铁蛋白。超灵敏,非竞争性免疫测定方法来测量阿托摩尔量的半抗原与氨基也已开发。半抗原,特别是肽,通过使用N-羟基琥珀酰亚胺生物素进行生物素化,并通过使用酶标记的抗肽Feb'和链霉亲和素包被的固相(异源双位点酶免疫测定)进行测量。少
项目成果
期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Seiichi Hashida, Koichiro tanaka, Shinobu Inoue, Kunio Hayakawa and Eiji Ishikawa: "Time-resolved fluorometric sandwich immunoassay for human growth hormone in serum and urine." Journal of Clinical Laboratory Analysis. 5. 38-42 (1991)
Seiichi Hashida、Koichiro tanaka、Shinobu Inoue、Kunio Hayakawa 和 Eiji Ishikawa:“血清和尿液中人类生长激素的时间分辨荧光夹心免疫分析。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Eiji Ishikawa,et al.: "Ultrasensitive enzyme immunoassay." Clinica Chimica Acta. 194. 51-72 (1990)
Eiji Ishikawa 等人:“超灵敏酶免疫测定法。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takeyuki Kohno,et al.: "Immune cumplex transfer enzyme immunoassay for (antiーhuman Tーcell leukemia virus type I)IgG in serum using a synthetic peptide,env gp46(188ー209),as antigen." Journal of Clinical Laboratory Analysis. 5. 25-37 (1991)
Takeyuki Kohno 等人:“使用合成肽 env gp46(188-209) 作为抗原,对血清中的(抗人 T 细胞白血病病毒 I 型)IgG 进行免疫复合物转移酶免疫测定。”分析。5. 25-37 (1991)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takeyuki Kohno, Iwane Sakoda and Eiji Ishikawa: "Immune complex transfer enzyme immunoassay for (anti-human T-cell leukemia virus type I) IgG in serum using a synthetic peptide, env gp46 (188-209), as antigen." Journal of Clinical Laboratory Analysis. 5.
Takeyuki Kohno、Iwane Sakoda 和 Eiji Ishikawa:“使用合成肽 env gp46 (188-209) 作为抗原,对血清中的(抗人 T 细胞白血病病毒 I 型)IgG 进行免疫复合物转移酶免疫测定。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Seiichi Hashida,et al.: "Detection of one milliattomole of ferritin by novel and ultrasensitive enzyme immunoassay." Journal of Biochemistry. 108. 960-964 (1990)
Seiichi Hashida 等人:“通过新型超灵敏酶免疫测定法检测一毫阿托铁蛋白。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ISHIKAWA Eiji其他文献
ISHIKAWA Eiji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ISHIKAWA Eiji', 18)}}的其他基金
Studies for practical use of novel ultrasensitive methods to detect HIV antigens and antibodies, improving the diagnosis of HIV infection
研究实际使用新型超灵敏方法检测 HIV 抗原和抗体,改善 HIV 感染的诊断
- 批准号:
08557016 - 财政年份:1996
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Studies for the Practical Use of Novel and Ultrasensitive Enzyme Immunoassay (Immune Complex Transfer Enzyme Immunoassary) of Anti-HTLV-I IgG Using Synthetic Peptides as Antigens
使用合成肽作为抗原的抗 HTLV-I IgG 的新型超灵敏酶免疫分析(免疫复合物转移酶免疫分析)的实际应用研究
- 批准号:
05557015 - 财政年份:1993
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Development and Applications of Novel Ultrasensitive Noncompetitive Immunoassay for Peptides
新型超灵敏多肽非竞争性免疫分析方法的开发及应用
- 批准号:
04808024 - 财政年份:1992
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Development of Novel, Ultrasensitive and Practical Enzyme Immunoassay for Anti-Thyroglobulin Autoantibodies
新型、超灵敏且实用的抗甲状腺球蛋白自身抗体酶免疫测定法的开发
- 批准号:
02557019 - 财政年份:1990
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Basic Study on Development of Ultrasensitive Enzyme Immunoassay for Antibodies
抗体超灵敏酶联免疫分析技术发展的基础研究
- 批准号:
62570119 - 财政年份:1987
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
COSMC/Tn antigen/mTOR 轴调控胃癌细胞转移的分子机制
研究
- 批准号:2024JJ9400
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
Shp2 在polyomavirus middle T antigen(mT)诱发肿瘤过程中的作用
- 批准号:30700392
- 批准年份:2007
- 资助金额:15.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines
艰难梭菌疫苗的范德比尔特抗体和抗原发现
- 批准号:
10625686 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Mapping T cell antigen-specificity in LGI1 antibody encephalitis
绘制 LGI1 抗体脑炎中 T 细胞抗原特异性图谱
- 批准号:
MR/X022013/1 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Research Grant
Construction of a predictive model for antigen-antibody interaction energies using the FMO database
使用FMO数据库构建抗原抗体相互作用能量的预测模型
- 批准号:
23K18192 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Developing a new bispecific antibody mimicking rapid antigen-specific memory CD8+ T cell-mediated protection
开发一种新型双特异性抗体,模仿快速抗原特异性记忆 CD8 T 细胞介导的保护
- 批准号:
10742118 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Class II Human Leukocyte Antigen biologics for antibody-mediated graft rejection.
用于抗体介导的移植物排斥反应的 II 类人类白细胞抗原生物制剂。
- 批准号:
10598931 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Regulation of antibody-related complement activation through specific antigen-antibody interacations
通过特异性抗原抗体相互作用调节抗体相关补体激活
- 批准号:
23H03748 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A Phase I trial of single domain antibody-based CD22 chimeric antigen receptor (CAR)-T cells for the treatment of relapsed/refractory CD22+ B-cell acute lymphoblastic leukemia
基于单域抗体的 CD22 嵌合抗原受体 (CAR)-T 细胞治疗复发/难治性 CD22 B 细胞急性淋巴细胞白血病的 I 期试验
- 批准号:
466359 - 财政年份:2022
- 资助金额:
$ 1.47万 - 项目类别:
Operating Grants
A Phase I trial of single domain antibody-based CD22 chimeric antigen receptor (CAR)-T cells for the treatment of relapsed/refractory CD22+ B-cell acute lymphoblastic leukemia
基于单域抗体的 CD22 嵌合抗原受体 (CAR)-T 细胞治疗复发/难治性 CD22 B 细胞急性淋巴细胞白血病的 I 期试验
- 批准号:
474613 - 财政年份:2022
- 资助金额:
$ 1.47万 - 项目类别:
Operating Grants
Machine learning driven antibody-antigen complex modelling and its applications to antibody therapeutics design
机器学习驱动的抗体-抗原复合物建模及其在抗体治疗设计中的应用
- 批准号:
2736508 - 财政年份:2022
- 资助金额:
$ 1.47万 - 项目类别:
Studentship
High-throughput mapping of human antibody sequences to PfEMP1 malaria antigen specificity
人类抗体序列与 PfEMP1 疟疾抗原特异性的高通量作图
- 批准号:
10447163 - 财政年份:2021
- 资助金额:
$ 1.47万 - 项目类别: